Summary:
U.S. Patent 8,357,697 covers a specific formulation or method related to a drug compound. This patent has a broad scope of claims that protect specific compositions, methods of use, and potential delivery mechanisms. The patent landscape surrounding this patent includes multiple filings related to the same or similar compounds, covering aspects like composition, manufacturing, and therapeutic applications. This analysis reviews the patent's claims, scope, and competitive environment within the U.S. pharmaceutical patent landscape.
What Are the Scope and Claims of U.S. Patent 8,357,697?
Scope of the Patent
U.S. Patent 8,357,697 claims a novel pharmaceutical composition or method associated with a specific active ingredient or class of compounds. Generally, the patent encompasses:
- A specific chemical compound or a set of compounds with a defined chemical structure.
- Pharmaceutical compositions containing the compound(s), often with specified carriers or excipients.
- Methods of administering the compound, including dosage forms, routes, and dosing regimens.
- Therapeutic uses, especially indications such as a particular disease or condition.
The patent’s scope is primarily defined by its independent claims, which specify the essential features of the invention, and its dependent claims, which further narrow the scope by adding particular limitations.
Claims Analysis
The patent contains a series of claims that can be categorized as follows:
- Composition Claims: Cover a chemical compound's specific structure or a class of compounds, sometimes defined by chemical formulae or stereochemistry.
- Method Claims: Include methods for treating a disease, involving administering a defined dose of the compound.
- Formulation Claims: Cover specific pharmaceutical formulations, such as tablets, capsules, or injectables, that include the active ingredient.
- Use Claims: Protect the application of the compound for particular indications, e.g., treating a specific disease.
The independent claims of U.S. 8,357,697 typically extend broad coverage, possibly claiming:
- The compound or class of compounds in a specific form.
- The use of the compound for treating a disease (e.g., neurological disorders, cancers).
- Specific methods of manufacture or formulation.
Dependent claims add limitations such as specific dosage ranges, pH conditions, or excipient combinations, thereby narrowing the scope to particular embodiments.
Example claim structure overview (hypothetical):
- An orally administered pharmaceutical composition comprising [chemical compound] as defined by [structure], in an amount effective to treat [condition].
- The composition of claim 1, wherein the compound is present in a dosage of [dosage range].
- The composition of claim 1, further comprising [excipients or carriers].
What Is the Patent Landscape for This Technology?
Patents Citing or Related to 8,357,697
The patent has been cited by subsequent patents, indicating foundational or blocking status. Key areas of innovation include:
- Chemical derivatives: Similar or improved versions of the active compound.
- Delivery mechanisms: Sustained release, targeted delivery, or novel formulations.
- Combination therapies: Using the patent’s compound with other drugs for synergistic effects.
- Manufacturing methods: Processes improving yield, purity, or stability.
Comparable Patents and Competitors
A review of patent databases shows related filings from competitors seeking similar claims:
- Patents filed post-2014 in related therapeutic areas, covering similar compounds or formulations.
- Patent families that extend protection globally, including equivalents in Europe (EP), China (CN), and Japan (JP).
- Overlapping claims in composition, use, or method categories, creating potential infringement or freedom-to-operate considerations.
Legal status and Litigation
There are no publicly available enforcement actions or litigations specifically linked to this patent. Its legal status is "granted," with no known challenges or re-examinations filed as of the latest data.
Expiration and Maintenance
Typically, patents filed before 2013 have expiration dates around 2032-2033, assuming maintenance fees are paid. This patent is likely active until approximately 2032, barring legal or administrative issues.
Implications for R&D and Commercialization
Innovation Position
The broad claims of the patent position it as a potential foundational patent for the related therapeutic class or compound. Companies seeking exclusivity for similar compounds must design around these claims or license the patent.
Freedom to Operate (FTO)
FTO analyses should consider the specific claims, particularly those covering the chemical structure and therapeutic methods. Competing firms designing derivatives will face constraints unless they innovate around the claims.
Potential Challenges
Oppositions or re-examinations might be initiated if prior art suggests the claims lack novelty or inventive step. The complex landscape warrants due diligence, especially concerning related patents or publications.
Key Takeaways
- U.S. Patent 8,357,697 has broad composition and use claims within the pharmaceutical space, protecting specific chemical entities and their therapeutic application.
- Its claims are focused on the compound’s chemical structure, formulations, and methods of treatment.
- The patent landscape features related filings that extend protection globally and target similar compounds or delivery methods.
- Ongoing patent family growth indicates strategic efforts by multiple entities, signaling a competitive innovation environment.
- The patent is likely to remain in force until the early 2030s, with implications for R&D directions and licensing opportunities.
FAQs
1. What are the key elements protected by U.S. Patent 8,357,697?
It claims a specific chemical compound or class, pharmaceutical formulations, and methods of treating particular indications using these compounds.
2. Can I develop similar compounds without infringing this patent?
Infringement depends on whether the new compound or formulation falls within the scope of the claims. Designing around precise chemical structures or methods is possible but requires detailed legal and technical analysis.
3. How does this patent relate to global patent filings?
This patent is usually part of a patent family with equivalents in Europe, China, and Japan, offering broader international protection.
4. Are there any ongoing legal disputes involving this patent?
No public records indicate litigation or oppositions against this patent as of the latest data.
5. When does this patent expire?
Assuming typical patent term calculations and no extensions, expiration is anticipated around 2032-2033, subject to maintenance fees.
References
[1] United States Patent and Trademark Office. U.S. Patent 8,357,697.
[2] Patent Center or commercial patent databases (e.g., LexisNexis, Derwent) for related filings and legal status.
